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Abstract
Aim. Atrial fibrillation (AFib) is a major clinical issue and its occurrence is the main problem
after catheter ablation of atrial flutter. The long-term occurrence of AFib after common atrial
flutter ablation is still matter of debate as it may influence the therapeutic approach. So, the aim
of our study was to analyze the determinants and the time course of AFib after radiofrequency
catheter ablation of chronic common atrial flutter. 
Methods and Results.  89 consecutive patients (67.5 ± 12.0 yrs) underwent RF ablation of
chronic common atrial flutter. 38.2 % had previous history of paroxysmal AFib. 51% had no
underlying structural heart disease. Over a mean follow-up of 38 ± 13 months, the occurrence
rate of AFib   progressively increased up to 32.9% at the end of follow-up. The median
occurrence time for AFib was 8 months. AFib occurrence was significantly associated with
previous AFib history (P=0.01) but not with the presence of underlying heart disease (P=n.s.). Of
particular interest, in our study, AFib never occurred in patients without previous AFib history.
Palpitations after chronic common atrial flutter ablation was mostly related to AFib. 
Conclusion.  In conclusion,  after chronic  common  atrial  flutter  ablation,  AFib  incidence
progressively increased over the follow-up in all patients. Patients with prior AFib history
appeared to be a very high risk group. In these patients, closer monitoring is mandatory and the
persistent risk of AFib recurrences may justify prolonged anticoagulation policy.
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Introduction
            As recently demonstrated by Natale et al catheter ablation has become first-line therapy
for common atrial flutter (AFL) in patients without structural heart disease and without left
atrium enlargement1. In a recent study by Anselme et al2, one third of the patients still
complained with palpitations after AFL ablation despite a significant improvement in quality of
life and these symptoms were mostly related to atrial fibrillation (AFib). AFib is a major cause of
morbidity and mortality, increasing risk for death congestive heart failure and stroke3.  Thus,
identifying patients with high risk of AFib occurrence after AFL ablation is of particularly high
importance as it may influence the therapeutic approach. After AFL ablation, the long-term
incidence of AFib is a major concern. However, despite numerous studies on catheter ablation of
atrial flutter data are still discordant. In some studies, the risk of AFib after AFL ablation
appeared to be decreased in patients with previous history of AFib4-6 though it was not in other
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(4): 272-278 (2005)Stéphane Cade, Shahine Sedighian, Agustin Bortone, Richard Gervasoni,                 273
Jean Christophe Macia, Florence Leclercq, Robert Grolleau and Jean Luc Pasquié, “Atrial
fibrillation and its determinants after radiofrequency ablation of chronic common atrial
flutter”
studies on large populations7-9. Moreover, some authors suggest from experimental studies an
increased risk of AFib in patients with chronic atrial flutter due to more severe atrial remodeling
compared to paroxysmal AFL10. 
            Thus, the aim of the present study was to determine the long-term incidence of atrial
fibrillation after chronic common atrial flutter ablation in a large population and to analyse its
determinants. 
Methods
Study patients and Ablation procedure
            We considered 89 consecutive patients referred to our institution for chronic common
AFL ablation. All patients were in chronic common AFL at the time of ablation procedure.
Patients were studied in the postabsorptive state under light sedation and after all antiarrhythmic
drugs except amiodarone had been stopped for > 5 half-lives. Based on the initially described
technique11, an electrophysiologically and anatomically guided ablation was performed in the
IVC-TA isthmus. The aim of the ablation was termination of AFL with restoration of sinus
rhythm associated to bidirectional block in the cavo-tricuspid isthmus as commonly described12. 
Long-term follow-up
            Patients were discharged the day after the procedure. Patients with previous AFib history
were discharged with antiarrhythmic (AA) therapy (amiodarone 200 mg/d or flecainide 200
mg/d). All patients had oral anticoagulants for at least 6 months after the procedure. Later follow-
up visits were performed by the referring cardiologist. The referring cardiologists were contacted
by telephone and asked about the “arrhythmic” status of the patients. All patients were contacted
by telephone to confirm their clinical status. Holter ECG recordings were systematically
performed at 1 month, 3 months, 6 months and every 6 months thereafter. When a patient
complained with palpitations, Holter ECG recordings were repeated until precise diagnosis was
made. 
Statistical analysis
            Continuous variables were expressed as mean +/- SD. When pertinent, we calculated the
median value as well as the 25th-75th percentile for each value to describe its distribution in the
population. We defined as “Median Occurrence Time 50” the median time of AFib occurrence
for 50 % of the population. The relationship between qualitative variables were assessed by Chi
square-test or Fischer Exact test depending on the size of the population. Actuarial freedom from
occurrence was determined using the method of Kaplan and Meier. The comparison of actuarial
freedoms depending on the presence or not of one considered factor (prior history of AFib; LVEF
< 50%; Chronic obstructive lung disease; AFib inducibility) was assessed using Log Rank test
and Wilcoxon test. A value of P < 0.05 was considered significant. 
Results
Study population
            We studied 89 patients (79 men/ 10 women; mean age: 67.5 ± 12.0 yrs.) with chronic
common isthmus-dependent AFL (Table 1). All of the patients were in chronic atrial flutter at
the time of the ablation procedure. Some of them had at least 1 previous episode of atrial
fibrillation before atrial flutter occurrence and were considered as pts with previous AFib. None
of them had AFL induced by Ic antiarrhythmic treatment.  The median duration of chronic AFL
before ablation procedure was 12 months (25th -75th percentile: 3-60 months). 38 % had
previous paroxysmal AFib (median: 48 months; 25th-75th percentile : 8-72 months) but AFL
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always remained the major symptomatic arrhythmia. All had failed several AA drugs and 92.1 %
had ongoing AA treatment including amiodarone in 71 patients. 49 % had LVEF < 50 %.  12 %
had previous CABG. Chronic obstructive lung disease was observed in 20 % of the patients. 
Initial results and Follow-up
            The mean follow-up duration was 38 ± 13 months. Eight patients died during follow-up
(1 cerebrovascular disease, 4 coronary artery disease, 1 heart failure, 1 lung cancer, 1 acute
respiratory failure in a pt with severe pulmonary disease). Two patients had dual-chamber
pacemaker for sinus dysfunction and symptomatic second degree AV block 18 and 21 months
respectively after ablation procedure. Thirty-four patients remained under AA therapy after the
ablation procedure.
            At the end of the 3-year follow-up, 32.9 % of the patients experienced AFib (Table 2).
The AFib “Median Occurrence Time 50” was 8 months (25th-75th percentile: 2-24 months,
Table 2). During follow-up, 9 patients with LVEF < 50% developed chronic AFib. The actuarial
freedom from AFib is represented on Fig 1. The actuarial freedom from AFib was significantly
decreased when previous AFib history was present (P = 0.001; Fig 1). No significant difference
in the actuarial freedom from AFib was found considering LVEF (Fig 1) and presence of chronic
obstructive lung disease.
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Figure 1 : Top : Actuarial freedom from atrial fibrillation episodes after ablation of chronic
common atrial flutter; (Middle) : Actuarial freedom from atrial fibrillation episodes after
ablation of chronic common atrial flutter considering the presence of previous history of atrial
fibrillation. AFib + indicates previous history of AFib; AFib – indicates no previous history of
AFib; (Bottom) : Actuarial freedom from atrial fibrillation episodes after ablation of chronic
common atrial flutter considering the LVEF < 50%. 
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Palpitations
            Among the study population, 53 out of 89 patients visited their referring cardiologist for
various symptoms. Twenty-seven patients complained with palpitations; only 4 of these patients
were free of any arrhythmia. On the contrary, 5 patients had asymptomatic AFib diagnosed by
Holter ECG recordings. However, palpitations were significantly associated to AFib episodes (P
= 0.01). 
Discussion
            In our study, after chronic common AFL ablation we observed a progressive increase in
AFib incidence up to 32.9 % at 3 years. Prior AFib history was the only determinant of AFib
incidence. Moreover, palpitations after AFL ablation were most of the time symptomatic of AFib
episodes. 
            The relationships between AFL and AFib are complex. In all of the previous studies
about AFL ablation13-20 a previous AFib history was present in 20 to 55 % of the population.
However, the AFib occurrence rate after AFL ablation varies widely in previously reported
series. This rate was as high as 43 % as reported by Philippon et al17, 37.5 % in the study of
Saoudi et al18 or 31 % for Hsieh et al9. In our study, 38.2 % of patients had previous AFib
history. After AFL ablation, we had a progressive increase in AFib occurrence reaching a 32.9
%-occurrence rate by 36 months. Some authors more recently concluded that AFL ablation could
reduce the incidence of AFib from 55 % to 33 % on a mean follow-up of 496 ± 335 days6. From
our results, it appeared that the main element was time i.e. the duration of follow-up as we had a
progressive increase in AFib occurrence rate. As a matter of fact, Gilligan et al8 showed a 59 %-
cumulative occurrence rate of AFib and atypical flutter at 2 years with only 27 % of patients
remaining still free of atrial arrhythmias at 5 years. This may also explain a lower AFib
occurrence rate of 28 % after ablation compared to a 53 %-AFib ocurrence rate before ablation
found by O’Callaghan et al16; the 28 %-AFib occurrence rate is the 12 month-value after AFL
ablation that is even higher than in our study after 1-year follow-up. Moreover, some authors
found an increased incidence of early AFib after AFL ablation20,21. These early episodes might be
transient  and self-limited19  or  associated  with  mitral regurgitation20.   In  our   study,  AFib
occurrence appeared progressive. These discrepancies between studies may be due to differences
in the mean age of the population and more advanced heart disease. This second point might
explain also the fact that patients with flutter only have a very low risk of fibrillation in our
follow-up, contrary to patients with previous AFib history. Some authors have discussed a
putative arrhythmogenic effect of ablation lesion4 or would have expected an increased risk for
AFib through more severe atrial remodelling during chronic AFL10, or may be through larger
anatomic conduction pathways in the chronic form22; in our study including only patients with
chronic common flutter such an arrhythmogenic effect was not detected. 
               However, our study confirmed the clinical benefit of AFL ablation described by
O’Callaghan et al16 or Anselme et al2. Most of the patients remained asymptomatic without any
AA treatment for patients without prior AFib history. Moreover, in agreement with Anselme et
al2, patients presenting with palpitations were mainly suffering from AFib. Among the possible
determinants of AFib occurrence after AFL ablation , prior AFib history appeared to be a major
factor. In a study by Philippon et al17, four factors were found to predict an increased risk for
developing AFib after AFL ablation: structural heart disease, previous history of AFib, high rate
pacing-induced AFib and a greater number of failed AA treatments in univariate analysis. In
multivariate analysis, only AFib inducibility was independently associated to late occurrence of
AFib19. In the same manner, Da Costa et al20 identified independent predictors of early AFib after
AFL ablation: left ventricular ejection fraction and pre-ablation history of atrial fibrillation. On a
longer follow-up, Hsieh et al showed that prior history of AFib and inducible AFib were
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independent predictors of early occurrence of AFib and that prior history of AFib was the only
independent predictor of late occurrence of AFib9. In our study, the only factor associated to
AFib occurrence was previous AFib history. As reported by Sparks et al10, chronic atrial flutter is
associated to increased early AFib inducibility but it is not demonstrated that it is associated to
AFib occurrence in the long term. As opposed to previous studies17,20,21, the presence of
structural heart disease (EF<50%) was not associatedwith increased AFib occurrence in our
study. These differences may be related to different stages of the arrhythmic atrial disease or of
the definition and severeity of structural heart disease as suggested by Da Costa et al20  and
Philippon et al17. Thus, the major determinant of AFib after AFL ablation appeared to be prior
AFib history. So, in patients undergoing AFL ablation, patients without prior AFib have a low
risk of arrhythmia recurrence after the procedure without any AA treatment and patients with
prior AFib have a high risk of arrhythmia recurrence. In these patients, AFL ablation will not
relieve   totally  the   symptoms   and   may  necessitate   complementary  treatment:   appropriate
anticoagulation, continuation of suppressive antiarrhythmic therapy or additional AFib ablation
procedure. 
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